Docetaxel is approved for advanced prostate Ca

Article

Docetaxel (Taxotere) has been approved by the FDA for the treatment of hormone-refractory metastatic prostate cancer when used in combination with prednisone.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.